ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,565,095 | +529.6% | 71,932 | +348.5% | 0.07% | +509.1% |
| Q1 2023 | $407,391 | -89.8% | 16,039 | -83.7% | 0.01% | -90.3% |
| Q4 2022 | $3,993,456 | +343.7% | 98,458 | +285.3% | 0.11% | +182.5% |
| Q2 2022 | $900,000 | +1.2% | 25,555 | +32.2% | 0.04% | -4.8% |
| Q1 2022 | $889,000 | +89.6% | 19,330 | +173.2% | 0.04% | +44.8% |
| Q4 2021 | $469,000 | -26.1% | 7,075 | -7.7% | 0.03% | -46.3% |
| Q2 2021 | $635,000 | -52.7% | 7,665 | -62.1% | 0.05% | -56.1% |
| Q1 2021 | $1,342,000 | -21.1% | 20,244 | -24.5% | 0.12% | +21.8% |
| Q4 2019 | $1,701,000 | +1123.7% | 26,812 | +39.2% | 0.10% | +910.0% |
| Q1 2018 | $139,000 | – | 19,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |